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Brucella abortus is a Gram-negative, facultative intracellular pathogen for several mam-
mals, including humans. Live attenuated B. abortus strain RB51 is currently the official
vaccine used against bovine brucellosis in the United States and several other countries.
Overexpression of protective B. abortus antigen Cu/Zn superoxide dismutase (SOD) in a
recombinant strain of RB51 (strain RB51SOD) significantly increases its vaccine efficacy
against virulent B. abortus challenge in a mouse model. An attempt has been made to better
understand the mechanism of the enhanced protective immunity of RB51SOD compared
to its parent strain RB51. We previously reported that RB51SOD stimulated enhanced
Th1 immune response. In this study, we further found that T effector cells derived from
RB51SOD-immunized mice exhibited significantly higher cytotoxic T lymphocyte activity
thanT effector cells derived from RB51-immunized mice against virulent B. abortus-infected
target cells. Meanwhile, the macrophage responses to these two strains were also studied.
Compared to RB51, RB51SOD cells had a lower survival rate in macrophages and induced
lower levels of macrophage apoptosis and necrosis. The decreased survival of RB51SOD
cells correlates with the higher sensitivity of RB51SOD, compared to RB51, to the bacteri-
cidal action of either Polymyxin B or sodium dodecyl sulfate (SDS). Furthermore, a physical
damage to the outer membrane of RB51SOD was observed by electron microscopy. Pos-
sibly due to the physical damage, overexpressed Cu/Zn SOD in RB51SOD was found to
be released into the bacterial cell culture medium. Therefore, the stronger adaptive immu-
nity induced by RB51SOD did not correlate with the low level of innate immunity induced
by RB51SOD compared to RB51. This unique and apparently contradictory profile is likely
associated with the differences in outer membrane integrity and Cu/Zn SOD release.
Keywords: Brucella abortus strains RB51 and RB51SOD, Cu/Zn superoxide dismutase (Cu/Zn SOD), innate immu-
nity, adaptive immunity, cytotoxic T lymphocyte (CTL), macrophage cell death, outer membrane integrity, protein
release
INTRODUCTION
Brucella abortus is a Gram-negative, facultative intracellular bac-
terium that causes brucellosis in humans and many animals
(Corbel, 1997). Brucellosis is one of the most common zoonotic
diseases. It infects approximately 500,000 humans annually world-
wide. The Brucella lack classical virulence factors, such as invasive
proteases, exotoxins, capsules, fimbriae, virulence plasmids, and
lysogenic phages. The virulence of Brucella relies heavily on their
ability to survive and replicate within the vacuolar phagocytic
compartments of macrophages (Baldwin and Winter, 1994; Roop
et al., 2009). As shown in the mouse model, the ability of dif-
ferent species or strains of Brucella to survive in macrophages
in vitro correlates with bacterial virulence in vivo. The virulence
of Brucella in vivo and their ability to survive in macrophages
in vitro correlates inversely with the innate resistance of the host
to brucellosis (Baldwin and Winter, 1994). The treatment of
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brucellosis remains difficult and requires antibiotics that penetrate
macrophages and can act in an acidic intracellular environment.
Brucella lipopolysaccharide (LPS) is a virulence factor that plays
a critical role in macrophage–Brucella interaction (Lapaque et al.,
2005). Smooth virulent Brucella strains contain an intact LPS, and
are capable of inhibiting programmed cell death in infected human
and mouse macrophages (Gross et al., 2000; Tolomeo et al., 2003;
He et al., 2006). Rough Brucella strains lack O-antigen or produce
extremely low levels of the antigen. Naturally occurring rough B.
canis and B. ovis strains are pathogenic in their preferred hosts
(Carmichael and Bruner, 1968; Rahaley and Dennis, 1984). Some
rough B. abortus strains have been found to survive and repli-
cate in macrophages (Pei and Ficht, 2004). However, most rough
strains of Brucella spp. are attenuated and cannot survive inside
macrophages (Fernandez-Prada et al., 2003; Rittig et al., 2003; Pei
and Ficht, 2004; Chen and He, 2009; Chen et al., 2011). Cattle bru-
cellosis vaccine strain RB51 is a rough live attenuated B. abortus
strain derived from smooth virulent strain 2308 (Schurig et al.,
2002). A safe, effective human brucellosis vaccine does not exist,
but it is needed to increase public health and biosafety. For ratio-
nal vaccine design, it is important to understand the mechanism
underlying protective Brucella immunity.
Cell-mediated immunity (CMI) plays an important role in
adoptive protective immunity to brucellosis. A T helper type
1 (Th1) immune response, indicated by IFN-γ production, is
required for protective Brucella immunity (He et al., 2001, 2002).
Cytotoxic T lymphocyte (CTL) activity is critical for protection
against brucellosis (Oliveira and Splitter, 1995; He et al., 2001).
RB51 vaccination of mice stimulates a strong Brucella-specific Th1
and CTL response (He et al., 2001). Recently, we reported that
RB51, but not its parent wild type strain 2308, induced caspase-
2-mediated apoptotic and necrotic murine macrophage cell death
(Chen and He, 2009). It is suggested that programmed cell death
of RB51-infected macrophages results in presentation of RB51
antigens in apoptotic vesicles to dendritic cells (DCs) and fur-
ther priming of Brucella-specific T cells through a process called
“cross-priming” (Yrlid and Wick, 2000; Winau et al., 2005).
The recombinant strain RB51SOD, which overexpresses Bru-
cella Cu/Zn superoxide dismutase (SOD) in RB51 (Vemulapalli
et al., 2000b), has been reported to induce a specific Th1 type
immune response to Cu/Zn SOD and to confer enhanced pro-
tection against a virulent B. abortus challenge (as compared to
RB51; Vemulapalli et al., 2002). Brucella Cu/Zn SOD is a periplas-
mic protein, and an appropriate immune response to this protein
confers protection against B. abortus challenge in a mouse model
(Vemulapalli et al., 2000b; He et al., 2002; Onate et al., 2003). Typ-
ically, BALB/c mice vaccinated with strain RB51 do not develop
significant levels of antibody or CMI to Cu/Zn SOD. However,
vaccination with strain RB51SOD stimulates the production of
SOD-specific antibodies and an IFN-γ response (Vemulapalli et al.,
2000b). Since RB51SOD is being tested to replace RB51 as an
improved cattle brucellosis vaccine, a large number of studies have
been conducted to ascertain why RB51SOD induces an enhanced
protection over that obtained with RB51. In order to stimulate
a robust adaptive response, a robust innate immune response is
usually essential. Surendran et al. recently reported that com-
pared to RB51SOD, RB51 stimulates an enhanced innate immune
response in murine bone marrow-derived DCs (Surendran et al.,
2010a) and in lung tissue in a mouse model (Surendran et al.,
2010b). Particularly, RB51 induced significantly higher DC mat-
uration and function compared to RB51SOD (Surendran et al.,
2010a). Compared to RB51SOD, intranasal mouse immunization
of RB51 induced: (a) more activated DCs, (b) higher production
of cytokines (e.g., TNF-α and IFN-γ) in bronchoalveolar lavage
(BAL), and (c) severer interstitial pneumonia in the lungs (Suren-
dran et al., 2010b). The observed apparent dilemma between
enhanced protection and a weakened innate immunity in vivo
and in DCs induced by RB51SOD is interesting. However, the
mechanism under this dilemma is unclear and deserves confirma-
tion and further investigation. Since macrophages are important
innate immune cells and the macrophage–Brucella interaction is
critical for Brucella pathogenesis, one critical step to understand
the dilemma between enhanced protection and weakened innate
immunity is to analyze the differences between RB51SOD and
RB51 in their interactions with macrophages. Another research
approach toward addressing this problem is to analyze the differ-
ences of these two strains in biophysical properties and resistance
to various bactericidal activities in vitro.
The goal of the present studies was to provide deeper insight
into the differential innate and adoptive immune responses
induced by RB51SOD versus RB51. We initially demonstrated
that RB51SOD induces a higher CTL activity against virulent
Brucella infection in vaccinated mice than RB51, which explains
the enhanced protection induced by RB51SOD. Secondly, we
studied interactions that occurred between RB51SOD/RB51 and
macrophages. These studies revealed that compared to RB51,
RB51SOD has a reduced survival capability inside macrophages
and induces a lower level of macrophage cell death. The reduced
survival inside macrophages correlates with the higher sensitiv-
ity of RB51SOD to the bactericidal action of either Polymyxin
B or sodium dodecyl sulfate (SDS). The reason for the differ-
ent sensitivities to the in vitro bactericidal activities is due to a
physical damage to the outer membrane of RB51SOD. We also
found that overexpressed Cu/Zn SOD in RB51SOD is released
into the bacterial cell culture medium. It is likely that compared
to RB51, the reduced outer membrane integrity (as shown by the
increased sensitivity to bactericidal activity of Polymyxin B and
SDS) in RB51SOD is associated with the weakened innate immu-
nity induced by RB51SOD. Furthermore, the enhanced protection
and adaptive immunity generated by RB51SOD is possibly due to
the overexpression of Cu/Zn SOD and its release into extracellular
area.
MATERIALS AND METHODS
BACTERIAL STRAINS AND MACROPHAGE CELL CULTURE
All bacterial strains were grown at 37˚C in tryptic soy broth
(TSB) or on tryptic soy agar (TSA; Difco/Becton-Dickinson,
Sparks, MD, USA). Studies utilizing live virulent Brucella strain
2308 were performed in a Biosafety level-3 (BSL-3) laboratory.
All other studies were conducted in a BSL-2 laboratory. Murine
macrophage cell lines J774A.1 (ATCC #TIB-67) and RAW264.7
(ATCC #TIB-71) were cultured at 37˚C in a 5% CO2 atmosphere
in a complete medium (c-DMEM) consisting of Dulbecco’s mod-
ified Eagle’s medium (DMEM; ATCC) supplemented with 10%
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heat-inactivated fetal bovine serum (HyClone, Logan, UT, USA).
Cultured macrophages, passages 3 and 14, were used in these
experiments. This study was approved by the University Commit-
tee on Use and Care of Animals (UCUCA #09695) in the University
of Michigan.
VACCINATION OF MICE
Four- to five-week-old female BALB/c mice were purchased
from Charles River laboratories (Wilmington, MA, USA). Groups
of four mice each were injected intraperitoneally (i.p.) with
∼4 × 108 cells (strain RB51 or RB51SOD). Saline served as nega-
tive control. The mice, sacrificed at 6–7 weeks post-vaccination by
CO2 inhalation, served as splenocyte sources for the CTL assay.
CYTOTOXIC T LYMPHOCYTE ACTIVITY ANALYSIS
A neutral red uptake CTL cytotoxicity assay was performed accord-
ing to a previously described in Section “Materials and Methods”
(He et al., 2001). Two mice from each group were sacrificed for
each CTL assay. The spleens from each group were pooled, and
the splenocytes isolated and passed though nylon wool columns
to enrich the T cell population in each preparation. Previous stud-
ies indicated processing through nylon wool does not change the
ratio of CD4+ and CD8+ T cells in the splenocytes (He et al.,
2001). Viable RB51 cells were used to infect J774.A1 macrophages
in a ratio of 100:1 for 4–5 h for preparing stimulator cells. The
infected macrophages were incubated at 37˚C with mitomycin C
(35 μg/ml) for 45 min. The antibiotic was removed by centrifu-
gation at 300 × g (4×). The macrophages (stimulator cells) were
mixed with enriched T cells in a ratio of 1:10 in 24-well cell culture
plates and incubated at 37˚C, under 5% CO2 for 5 days. The cells
were collected and the live effector T cells purified on a Histopaque
column (He et al., 2001). Infected target cells were prepared by
infecting J774.A1 macrophages at 37˚C, under 5% CO2 for 4–5 h
with strain 2308 in a ratio of 100:1. Normal J774.A1 cells served as
control target cells. A series of dilutions of effector T cells were per-
formed in 96-well round-bottom cell culture plates in triplicate,
and target cells were added at concentrations of 50,000 cells/well.
The effector T cells and target cells were incubated at 37˚C, under
5% CO2 for 16 h. Target cells lacking effector cells served as con-
trols. The culture medium was carefully removed, and 200 μl of
warm neutral red solution (0.036%) were added to each well. Fol-
lowing incubation at 37˚C for 40 min, the cell monolayers were
washed for three times with 37˚C phosphate-buffered saline (pH
7.2–7.4), and the cells lysed in 0.05 M acetic acid–0.05% SDS solu-
tion (220 μl/well). Aliquots of 200 μl were removed from each well,
transferred to 96-well ELISA microplates, and the OD570 recorded
using an ELISA microplate reader. The percentage of specific lysis
was established by applying the formula: specific lysis = (OD of
control − OD of experimental group/OD of control × 100; He
et al., 2001).
ANALYSIS OF BRUCELLA SURVIVAL INSIDE MACROPHAGES
RAW264.7 macrophages were cultured in 24-well plates at
2.5 × 105 cells/well and incubated at 37˚C overnight. Small vol-
umes of BrucellaRB51 and RB51SOD cultures contained in TSB
were diluted in 1:100 and cultured in TSB overnight. Cell numbers
were calculated spectrophotometrically. An OD600 of one approx-
imated 3 × 109 Brucella cells (Sun et al., 2005). Macrophages
were infected with Brucella at different multiplicities of infec-
tion (MOIs). The plates were centrifuged at room temperature
for 5 min at 300 × g. All incubations were conducted at 37˚C
in an atmosphere containing 5% (vol/vol) CO2. After 1 h the
cells were washed three times with Dulbecco’s phosphate-buffered
saline (DPBS), and incubated in fresh DMEM supplemented with
50 μg/ml of gentamicin to kill extracellular bacteria. To assess the
intracellular survival of Brucella inside macrophages, the cells were
lysed with 1 ml of sterile 0.1% (vol/vol) Triton X-100 at 1, 6, 24, and
48 h post infection, respectively. The number of colony forming
units (CFUs) was obtained by plating a series of dilutions on TSA
plates. All experiments were conducted in biological triplicates,
i.e., different replicates using macrophages from different flasks
of culture and Brucella cells originating from different Brucella
colonies.
DETERMINATION OF PROGRAMMED MACROPHAGE CELL DEATH
RAW264.7 macrophages were infected using the same proto-
cols described above except that macrophages were cultured in
six-well plates at 1 × 106 cells/well. At different time points, apop-
totic and necrotic macrophages were detected by staining with
AnnexinV (green dye) and propidium iodide (PI, red dye) using an
Annexin V-FLUOS staining kit (Roche Diagnostics Corporation,
Indianapolis, Ind.; Chen and He, 2009). RB51 and RB51SOD-
infected macrophages were incubated at room temperature for
20 min with Annexin V and PI. Fluorescence was observed with a
Nikon TE2000-S microscope. Images were photographed with an
RT Side Spot digital camera. Apoptotic and necrotic cell numbers
were counted in representative fields containing at least 100 cells.
To quantitate macrophage cell viability, cells infected with
RB51 or RB51SOD were cultured in triplicate in 96-well plates
(described above). The culture supernatants were collected at vary-
ing time points, and the lactate dehydrogenase (LDH) released
(used as a viability criteria) quantized with a CytoTox 96 non-
radioactive cytotoxicity assay kit (Promega, Madison, WI, USA)
according to the manufacturer’s instructions (Chen and He, 2009).
The percent of dying/membrane-damaged cells was expressed as
a percentage of the maximum amount of LDH released.
ASSAYS FOR BACTERIAL RESISTANCE TO BACTERICIDAL ACTIVITIES
BY CHEMICAL DETERGENTS
The comparative sensitivities of RB51SOD and RB51 to the bacte-
ricidal action of Polymyxin B (PmB) and sodium dodecyl sulfate
(SDS) were measured. The PmB sensitivity assay was essentially
that of Allen et al. (1998). Specifically, the Brucella were grown
to log phase in TSB, pelleted at 4,200 × g, resuspended in 10 mM
phosphate buffer (pH 7.2) at approximately 4 × 104 CFU/ml, and
incubated at 37˚C for 1 h with several concentrations of PmB (500,
250, 125 and 62.5, 31.25, 15, 7.5 μg/ml, respectively). Following
incubation, the cell suspensions were serially diluted (1:10) in
10 mM phosphate buffer (pH 7.2), and 50 μl aliquots were plated
in triplicate TSA plates. After 4 days of culturing in 37˚C with 5%
CO2, the colonies on the plates were counted and used to calcu-
late the bacterial CFU under different PmB concentrations. The
results of three assays were averaged. The PmB bactericidal activ-
ity was expressed as a percentage of the Brucella surviving in wells
incubated in the absence of bactericidal agents. To test for SDS
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susceptibility, bacteria were pelleted at 3000 × g, washed once in
20 mM Tris–HC1 buffer, pH 7.5, and resuspended in the same
buffer to an OD600 approximating 1.0. The cells were incubated at
37˚C for varying periods of time in 0.3% SDS, and the decrease in
optical density at 600 nm monitored (Georgiou and Shuler, 1988).
ELECTRON MICROSCOPY
RB51 and RB51SOD were cultured in TSB to the late log phase.
After centrifugation, the cell pellets were fixed for 1 h in an ice-cold
solution of 2.5% glutaraldehyde and 4% formaldehyde in 0.1 M
isosmotic phosphate buffer, pH 7.4. The fixative was decanted,
and each sample washed for 15 min with three changes of 0.1 M
phosphate buffer. The samples were then fixed at 4˚C in 1% OsO4
contained in 0.1 M phosphate buffer for 1.5 h, washed three times
for 15 min in the same solution and dehydrated with multiple
washes in ethanol of decreasing water content. The samples were
infiltrated with epoxy resin, and embedded in Spurr medium (Ted
Pella Inc., Redding, CA, USA). Ultrathin sections were prepared
with a microtome and mounted on copper/rhodium mesh grids
M150-CR (Electron Microscopy Sciences, Fort Washington, PA,
USA). The grids were stained with uranium acetate and lead cit-
rate and examined in a Philips CM 100 transmission electron
microscope (Borisov et al., 2008).
DETECTION OF OVEREXPRESSED SOD RELEASE IN RECOMBINANT
STRAIN RB51SOD
To detect release of SOD from recombinant RB51 strains, strains
RB51 and RB51SOD were grown in TSB medium to a cell density
of ∼5 × 108 cells/ml. The supernatants from 10 ml of culture were
treated with cold trichloroacetic acid (TCA), a final concentration
of 20%, incubated at 4˚C overnight, and centrifuged at 15,000 × g
for 30 min (Metcalf and Wanner, 1993). The pellets were washed
with acetone, dissolved in 100 μl of Laemmli sample buffer (2×),
boiled for 5 min, and the protein constituents resolved by SDS-
PAGE on 12.5% acrylamide gels (Vemulapalli et al., 2000b). For
each sample, 20 μl of prepared solution was used in a standard
SDS-PAGE experiment (He et al., 2002). The gels were stained with
Coomassie brilliant blue R-250 or transferred to polyvinylidene
difluoride (PVDF) membranes for Western blot analyses (Chen
and He, 2009).
AMINO ACID SEQUENCING
The SDS-PAGE gels were electro-transferred to PVDF mem-
branes with CAPS transfer buffer (10 mM 3-[cyclohexylamino]-1-
propanesulfonic acid, 10% methanol, pH 11.0; Matsudaira, 1987).
The resolved proteins were visualized by staining with Coomassie
brilliant blue R-250, destained with 50% methanol, and washed
with distilled water. The membranes were dried and used for
analysis of their amino acid sequences by Midwest Analytical, Inc.
(St. Louis, MO, USA). The sequences detected were subjected to
a BLAST search [National Center for Biotechnology Information
(NCBI)] to identify the proteins.
STATISTICAL ANALYSES
The data from appropriate experiments were analyzed using the
Microsoft Excel statistics package. Analysis of variance (ANOVA)
or t -test was used for statistical analysis of experiments results
obtained from various experimental assays.
RESULTS
RB51SOD INDUCES A HIGHER LEVEL OF CYTOTOXICITY AGAINST
VIRULENT BRUCELLA THAN RB51
Since the CTL activity is critical to protective Brucella immu-
nity, we hypothesized that in mice RB51SOD would induce a
higher level of CTL activity than RB51. To test this hypoth-
esis, the cytolytic ability to lyse virulent Brucella infected tar-
get macrophages by effector T cells from immunized mice was
detected using a neutral red uptake assay (He et al., 2001).
Neutral red is taken up by viable, infected, or non-infected target
macrophages but not by residual live effector cells or dead cells. The
ability of B. abortus-specific CTLs from strain RB51 or RB51SOD-
immunized mice to lyse virulent B. abortus strain 2308-infected or
uninfected J774.A1 macrophages was determined (Figure 1). Spe-
cific lysis of strain 2308-infected target cells was detected by T effec-
tor cells derived from each Brucella strain. Four different effector
cell/target cell (E/T) ratios were used. RB51SOD induced signif-
icantly greater lysis (P-value < 0.05) against strain 2308-infected
macrophages than RB51. Only a small level of lysis was observed
when the T effector cells were incubated with non-infected J774.A1
macrophages.
DECREASED BRUCELLA SURVIVAL AND DECREASED PROGRAMMED
CELL DEATH IN MACROPHAGES INFECTED BY RB51SOD COMPARED TO
RB51
A strong adaptive response usually accompanies a strong innate
immune response. The macrophage response is an important
FIGURE 1 | RB51SOD induces greater CTL activity against virulent
Brucella-infected macrophage target cells than RB51. T cells were
isolated from spleens of BALB/c mice immunized with RB51 (triangles) or
RB51SOD (squares). T effector cells were cocultured at various ratios with
either virulent strain 2308-infected macrophages (solid triangles and
squares) or normal uninfected J774.A1 macrophages (unfilled triangles and
squares). CTL cytotoxic activity was measured using the neutral red uptake
assay described in Section “Materials and Methods.” The data presented
are means of triplicate estimations. RB51SOD induced significantly more
lysis against strain 2308-infected macrophages than strain RB51
(P -value < 0.05). The T effector cells derived from saline-injected mice did
not lyse any target cells (data not shown). The sign ∗ represents statistical
significance (P -value < 0.05).
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form of innate immunity. The interaction between macrophages
and Brucella is key to chronic Brucella infection. To estab-
lish whether a possible correlation between innate and adap-
tive immunities induced by RB51SOD and RB51 exists, we
focused our comparative analysis on macrophage responses to
RB51SOD and RB51. The kinetic profiles of intracellular sur-
vival of Brucella strains RB51 and RB51SOD were analyzed in
concert with the cell death of infected macrophages (Figures 2–
4). Macrophages were infected with RB51 or RB51SOD. At
1 h post infection, the number of RB51 cells found inside the
macrophages was similar to that found with RB51SOD. How-
ever, at 6 and 24 h post infection, RB51SOD exhibited a signif-
icantly lower number (approximately one Log or 10-fold less)
of surviving cells inside macrophages than RB51(P-value < 0.05;
Figure 2).
Our previous study revealed that RB51 induces apoptotic and
necrotic cell death in infected macrophages (Chen and He, 2009).
We have also found that similar to another rough, live attenu-
ated Brucella strain VTRS1 (Chen et al., 2011), RB51-induced
macrophage cell death is proinflammatory (data not shown).
This new result suggests that RB51-induced macrophage cell
death differs from classical non-proinflammatory apoptosis. It is
further hypothesized that RB51-induced macrophage cell death
will induce cross-priming that results in Brucella-specific T cell
maturation and activation (Chen and He, 2009). Therefore, a
possible difference in the level of RB51- or RB51SOD-induced
macrophage cell death might lead to induction of different lev-
els of protection against virulent Brucella infections (Vemula-
palli et al., 2000b). Based on these phenomena and hypothe-
sis, establishing whether RB51SOD would induce programmed
macrophage cell death and to what level was of interest. Lac-
tate dehydrogenase (LDH) release was used to determine the
FIGURE 2 | Growth kinetics of RB51 and RB51SOD inside
macrophages. The data represent the means ± SD from three independent
experiments with an MOI of 200. The sign ∗ represents statistical
significance (P -value < 0.05).
cytopathic effect of RB51SOD or RB51 on infected macrophages.
The results of this assay revealed that RB51SOD induced a lower
level of cell death than RB51 at 6 h post infection and remained
lower with time (P-value < 0.05; Figure 3). To further ana-
lyze the pattern of cell death in Brucella-infected macrophages,
infected cells were stained with Annexin V (green) and propid-
ium iodide (PI, red; Chen and He, 2009). The result of fluo-
rescence staining of infected macrophages indicated that rough
B. abortus strains RB51 and RB51SOD each exhibited apoptotic
(stained green) and necrotic (stained green and red) macrophage
cell death. At 24 h post infection with RB51 and RB51SOD,
the cells that underwent either apoptotic or necrotic cell death
contained 38.4 and 16.3% of infected macrophages, respectively
(Figure 4). Therefore, compared to RB51SOD, a twofold reduc-
tion in cell death was observed in RB51-infected macrophages
at 24 h post infection. These results indicate that RB51SOD
induces less programmed cell death of infected macrophages than
RB51.
COMPROMISED RESISTANCE OF RB51SOD TO BACTERICIDAL ACTIVITY
BY CHEMICAL DETERGENTS
Why does RB51SOD have a lower survival inside macrophages?
The lower survival inside macrophages often correlates with com-
promised resistance to bactericidal activity induced by chemical
detergents. To test this, RB51SOD and RB51wereexposed sep-
arately to Polymyxin B sulfate (PmB) or SDS, and the lytic
sensitivity to each reagent was determined. Polymyxin B sulfate
(PmB), a strongly cationic cyclic polypeptide antibiotic, binds to
and neutralizes LPS. Specifically, PmB forms ionic interactions
with oligosaccharide components of LPS, including 2-keto-3-
deoxyoctulosonic acid and phosphate. PmB has been frequently
used as a model defensin, a cationic and amphipathic peptide
which functions within phagocytic cells (e.g., macrophages) by
permeabilizing the cytoplasmic cell membranes of Gram-negative
organisms (Allen et al., 1998). PmB has a strong bactericidal
FIGURE 3 | LDH release as a measure of macrophage cell death
induced by infection of RB51 or RB51SOD. The data represent the
means ± SD from three independent experiments, each with an MOI of
200. The sign ∗ represents statistical significance (P -value < 0.05).
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affect against rough B. abortus, reflecting the actions of relevant
components of the oxygen-independent systems of phagocytes
(Martinez De Tejada et al., 1995). PmB increases the permeability
of the outer membrane of Gram-negative bacteria (Vaara, 1992).
Differential resistances of Brucella strains to the PmB bacterici-
dal activity also indicate different outer membrane integrities.
When PmB was used, RB51SOD survival as measured by CFU
counts was reduced relative to that observed with RB51 over a
FIGURE 4 | Apoptotic and necrotic cell death of macrophages infected
with RB51 or RB51SOD at 24 h post infection. Annexin V (green) and PI
(red) were used to stain uninfected or infected RAW264.7 macrophages.
The MOI for Brucella infection was 200.
PmB concentration range of 7.5–500 μg/ml. RB51SOD exhibited
greater sensitivity (P-value < 0.05) to PmB at all tested concen-
trations below 100 μg/ml (Figure 5A). For example, with a PmB
concentration of 31.25 μg/ml, approximately 41% of RB51 cells
survived inside macrophages; however, only 26% of RB51SOD
cells survived. This is an approximately 1.6 fold reduction in terms
of bacterial survival inside macrophages.
Sodium dodecyl sulfate (SDS) is an anionic surfactant and
amphiphilic detergent that has frequently been used in testing
bacterial resistance to lytic activity and bacterial outer mem-
brane integrity (Georgiou and Shuler, 1988). Similarly to PmB,
RB51SOD also showed a greater sensitivity to the bacteriolytic
activity of SDS (Figure 5B) at different time points within 80 min.
For example, at 80 min after exposure to 0.3% of SDS, the OD600
value of RB51 and RB51SOD suspensions were approximately 0.8
and 0.65, respectively. This is approximately 15% of reduction in
OD600 value. Considering the dead bacteria also contribute to OD
value, more than 15% of live bacterial reduction likely occurred
at this condition. Overall, the results indicate that the RB51SOD
cells were lysed faster than RB51 by SDS (Figure 5B).
DAMAGED OUTER MEMBRANE INTEGRITY OF RB51SOD CELLS
The increased sensitivity of RB51SOD over that of RB51 to PmB
and SDS suggests that the integrity of the outer membrane of
RB51SOD is compromised. To test a possible physical damage
of RB51SOD outer membranes, transmission electron micro-
scope analysis was performed (Figure 6). Approximately 5–10% of
RB51SOD cells exhibited “physical damage.” In contrast, no phys-
ical damage was observed in RB51 samples (Figure 6A). Large
gaps of the cell membrane and obvious membrane damage were
observed on the surface of RB51SOD cells in log phase growth
(Figures 6B,C). This phenomenon differs from outer membrane
“vesicle blebs” which are usually small and do not disrupt the cell
membrane (Kuehn and Kesty, 2005).
FIGURE 5 | Sensitivity of RB51SOD to the bactericidal activity
of Polymyxin B and SDS. (A) Percentage survival for 1 h after
exposure to the indicated range of Polymyxin B concentrations.
(B) Decrease in OD600 after Brucella exposure to 0.3% SDS for
increasing periods of time. The sign ∗ represents statistical significance
(P -value < 0.05).
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FIGURE 6 | Electron microscopy of RB51 and RB51SOD outer membrane damage. RB51 lacked outer membrane damage (A). Outer membrane damage
appeared on the surface of RB51SOD (B,C). The scale bar represents a length of 100 nm.
RELEASE OF OVEREXPRESSED SOD BY RECOMBINANT STRAIN
RB51SOD
The compromised integrity of the outer membrane may lead to
release of periplasmic proteins. Overexpression of Cu/Zn SOD
in the recombinant strain RB51SOD has been documented in
previous studies (Vemulapalli et al., 2000b, 2002). An elevated
level of Cu/Zn SOD protein is present inside intact RB51SOD
cells compared to the level found in RB51 (Vemulapalli et al.,
2000b, 2002). To further test whether overexpressed Cu/Zn SOD
is released from inside RB51SOD cells, culture supernatants of
recombinant strain RB51SOD and RB51 were precipitated with
TCA. The precipitate were subjected to SDS-PAGE and stained
with Coomassie blue (Figure 7A). The precipitates from recombi-
nant strain RB51SOD migrated as a single protein that comigrated
with authentic SOD, and exhibited an approximate molecular
mass of 16 kDa (Figure 7A). The protein also reacted with anti-
SOD antibodies on Western blot analysis (Figure 7B). No proteins
that reacted with anti-SOD antibodies were present in the TCA
precipitated culture supernatant of strain RB51.
The release of Cu/Zn SOD into the culture supernatant of
strain RB51SOD was confirmed by subjecting the protein con-
tained on the PVDF membrane to amino acid sequencing. The
first 10 amino acids from the N-terminal end of the protein had
the sequence: ESTTVKMYEA. This sequence is identical to the
sequence reported for B. abortus Cu/Zn SOD in the NCBI pro-
tein database (NCBI RefSeq number YP_418725.1 and UniProt
Accession number P15453). A bioinformatics analysis revealed
that the N-terminal signal sequence: MKSLFIASTMVLMAFPAFA
had been cleaved. This cleavage accounts for the approximately
2 kDa difference between the molecular weights of the released
protein we observed in this study and the Brucella Cu/Zn SOD
including the signal sequence (Vemulapalli et al., 2000b).
To assess if the release of overexpressed proteins in recombinant
Brucella RB51 strains is a general phenomenon, similar analyses
were performed on TCA precipitates of recombinant RB51 strains
overexpressing the homologous Brucella cytosolic antigens GroEL
and GroES. Neither of the two overexpressed proteins was released
into the extracellular medium (data not shown). Taken together,
FIGURE 7 | Secretion of overexpressed Cu/Zn SOD by RB51SOD but
not by RB51. Bacterial supernatants of 10 ml cultures were precipitated by
TCA, processed by SDS-PAGE, and stained with Coomassie brilliant blue
(A) or subjected to Western blot analysis (B). Lane 1, RB51 culture
supernatant; lane 2, RB51SOD culture supernatant; lane 3, authentic
Brucella Cu/Zn SOD; and lane 4, molecular weight markers. The Cu/Zn SOD
protein band observed had a molecular mass approximating 16 kDa.
the above results suggest that release of Cu/Zn SOD in recom-
binant RB51 strains is restricted to overexpressed periplasmic or
outer membrane proteins.
DISCUSSION
There is no safe and effective Brucella vaccine available for human
use. Because of its enhanced vaccine efficacy RB51SOD has been
tested as a possible cattle vaccine candidate to replace RB51. An
in depth investigation of the mechanism of RB51SOD-induced
enhanced protection will enhance our understanding of protective
Brucella immunity and lend support to a rational vaccine design
for developing a safe and effective Brucella vaccine in humans.
This study provided new data for characterization of RB51SOD
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in an effort to better understand uncorrelated innate and adaptive
immune responses induced by RB51SOD and RB51. Specifically, as
expected, RB51SOD induces an enhanced Th1 immune response
(Vemulapalli et al., 2000b) and CTL activity (Figure 1) com-
pared to RB51. However, RB51SOD has decreased survival in
macrophages and is less efficient in inducing macrophage cell
death than RB51. During attempts to clarify this phenomenon,
it became apparent that RB51SOD has a compromised resistance
to bactericidal activity and physical outer membrane damage that
lead to the release of overexpressed periplasmic Cu/Zn SOD.
Previous studies demonstrated that RB51SOD induces strong
Th1 immune responses as indicated by the induction of a high level
of interferon-γ (IFN-γ) production (Vemulapalli et al., 2000b).
However, not all Brucella antigens that induce a Th1 type of
immune response are capable of generating protective immu-
nity. For example, Brucella heat shock proteins (HSPs) such as
GroEL and HtrA induced strong Th1 type of immune responses
with high IFN-γ production, but cannot induce protective immu-
nity against virulent Brucella challenges (Bae et al., 2002; Leclerq
et al., 2002). B. abortus YacD also induces IFN-γ production but
no protection against virulent Brucella (Vemulapalli et al., 1998).
Indeed, as a critical adaptive immunity, CTL activity appears
to have a better correlation with protective Brucella immunity
(He et al., 2001). Therefore, we performed a CTL activity assay
to compare the adaptive immune responses induced by these
two strains against virulent Brucella infections. Our study indi-
cated that RB51SOD induces a stronger CTL response against
virulent B. abortus-infected macrophage target cells than the non-
overexpressing strain RB51 (Figure 1). The enhanced CTL activity
induced by RB51SOD is critical for enhanced vaccine protection
induced by RB51SOD. Previous studies have demonstrated that
Brucella sodC encoded in DNA vaccine (Munoz-Montesino et al.,
2004), in an RNA vaccine (Onate et al., 2005), or in a fused to
IL-2 (Gonzalez-Smith et al., 2006) was able to induce Brucella
Cu/Zn SOD-specific CTL activity against Brucella-infected target
cells. Interestingly, live RB51SOD was used in all these studies to
infect macrophages for generation of stimulator cells in the CTL
assays. Our result is consistent with those shown in these studies,
suggesting that RB51SODinduces SOD-specific CTL activity.
Surendran et al. reported that RB51SOD stimulates a lower
innate immune response in lungs after intranasal immunization
in vivo (Surendran et al., 2010b) and in murine bone marrow-
derived DCs compared to RB51(Surendran et al., 2010a). Since
macrophages are important innate immune cells that interact
with Brucella at an early stage in infection (Baldwin and Win-
ter, 1994), we focused our analysis on the interactions between
macrophages and these two Brucella strains. We discovered the
reduced survival of RB51SOD inside macrophages, which may
result in decreased innate immune responses in vivo in other tis-
sues (e.g., lung) and cells (e.g., DCs) as well. The reduced survival
of RB51SOD inside macrophages appears to result from RB51SOD
outer membrane damage. Due to the RB51SOD outer membrane
damage, RB51SOD becomes more sensitive than RB51 to bacteri-
cidal action of Polymyxin B (a cationic polypeptide antibiotic)
and to SDS (a detergent; Figure 5). This finding may explain
the reduced capability of RB51SOD to resist various brucellacidal
mechanisms in macrophages (Baldwin and Winter, 1994) than
RB51 and may lead to its decreased level of survival inside
macrophages (Figure 2). All these further explain the reduced
innate immunity induced by RB51SOD compared to RB51. It
is noted that our previous study (Vemulapalli et al., 2000a) and
another independent report (Allen et al., 1998) have indicated
that wild type strain 2308 (the parent strain of RB51) is resistant
to the bactericidal activity of Polymyxin B. These confirmed the
importance of intact O-antigen to Brucella resistance to bacterici-
dal activity of chemical detergents. More studies are also deserved
to identify the differences of RB51SOD and RB51 in vivo in a real
life immunization scenario, including their serum sensitivity.
The RB51-induced programmed macrophage cell death may
release apoptotic vesicles that contain Brucella antigens that acti-
vate DCs and CD8+ T cells. This process of CD8+ T cell activation
is called“cross-priming.”The cross-priming process presents anti-
gens acquired from outside the cell (Bevan, 2006). This detour
pathway differs from the classical MHC class I antigen presentation
pathway (or called endogenous pathway) that presents intracellu-
lar antigens (e.g., antigens synthesized by viruses or intracellular
bacteria inside cells) to MHC class I molecules. Cross-priming
can be initiated through apoptotic macrophages induced by Sal-
monella (Yrlid and Wick, 2000), M. tuberculosis (Winau et al.,
2005), and influenza virus (Albert et al., 1998). We found that
RB51SOD-induced less macrophage cell death probably due to the
compromised resistance to macrophage bactericidal killing and
reduced survival of RB51SOD inside macrophages. It is hypoth-
esized that RB51 activates CTL activity by cross-priming (Chen
and He, 2009). If this is the case, the reduced macrophage cell
death and decreased Brucella survival inside macrophages will not
lead to an enhanced cross-priming process and, therefore, cannot
explain the enhanced protection induced by RB51SOD. Therefore,
other possible mechanism(s) are likely to exist in the induction of
enhanced protective immunity.
It is interesting to note that overexpressed Cu/Zn SOD is
released from RB51SOD (Figure 7). Overexpression of recom-
binant periplasmic proteins such as PhoS, β-Lactamase, and
cytochrome b5 in E. coli results in their release (Pages et al., 1987;
Georgiou and Shuler, 1988; Kaderbhai et al., 1997). Many Bru-
cella proteins have been found to be secreted or released from
live Brucella species in vitro or in vivo. For example, Caron
et al. (1996) reported that an unidentified protein-like mole-
cule(s) was “secreted” into the culture medium of B. suis. The
protein exhibited inhibitory activity against TNF-αproduction in
human macrophages. Boigegrain et al. (2004) reported that at
pH 4.0 in minimal medium or citrate buffer, B. suis was able to
secrete periplasmic proteins through the blebbing of the outer cell
membrane. Recently, Brucella protein RicA was identified to be
a secreted effector that interacts with human small GTPase Rab2
(De Barsy et al., 2011). Many secreted Brucella proteins are reg-
ulated by Brucella Type IV secretion systems (Marchesini et al.,
2004; De Jong et al., 2008; Delpino et al., 2009). VceA and VceC,
members of the VjbR regulon, were found to be translocated into
macrophages through the Brucella type IV secretion system (De
Jong et al., 2008). Delpino et al. (2009) found 11 Brucella proteins
secreted to culture supernatants in wild type Brucella but not in a
virB10 mutant. To the best of our knowledge, the release of over-
expressed SOD from strain RB51SOD is the first demonstration
of a Brucella protein released by Brucella cells overexpressing
a periplasmic protein. This release is likely due to the physical
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damage occurring in the RB51SOD outer membrane (Figure 6).
However, it remains to be determined whether this release effect is
specific to the overexpression of periplasmic Cu/Zn SOD.
Since the release of overexpressed Cu/Zn SOD is a phenome-
non associated with RB51SOD but not with RB51, it is interesting
to suggest that there may exist a possible relation between its
release and its enhanced vaccine efficacy. A number of reports
suggest that the secretory, or released proteins, of intracellu-
lar bacterial pathogens are superior protective antigens since
they are released to cytosol inside antigen presenting cells (e.g.,
macrophages) and processed through the classical MHC class I
antigen presentation pathway, which in turn leads to the stim-
ulation of protective CD8+ cytotoxic T cells (Hess et al., 1996,
1997; Harty and Bevan, 1999; Grode et al., 2001). For exam-
ple, secreted antigens of Mycobacterium tuberculosis and Listeria
monocytogenes, rather than constitutive or stress proteins, have
been found to be superior protective antigens (Orme, 1988, 1997).
Shen et al. (1998) demonstrated effective CD8+ T cell-dependent
immunity to recombinant L. monocytogenes (rLM) expressing a
model CD8+ T cell epitope from the nucleoprotein of lympho-
cytic choriomeningitis virus (LCMV) in secreted form but not
against rLM expressing the same epitope in non-secreted form.
Interestingly, when a recombinant Salmonella typhimurium aroA
vaccine strain was constructed so as to secrete Listeria SOD (a
non-secretory protein in wild type Listeria), protection against
a lethal L. monocytogenes challenge was obtained (Hess et al.,
1997). In contrast, a S. typhimurium aroA vaccine expressing a
non-secretory form of the listerial SOD was unable to induce
protection against lethal listeriosis. Therefore, it is likely that the
enhanced protection induced by RB51SOD is induced by the
release of overexpressed Brucella Cu/Zn SOD into macrophage
cytosol and the processing of this released protective antigen by
macrophages through the classical MHC class I antigen presen-
tation pathway (instead of cross-priming), leading to the prim-
ing of Brucella-specific CTL. However, current data does not
support the association between the Cu/Zn SOD release and
its processing through MHC class I antigen presentation path-
way. Further investigation is required to substantiate such an
association.
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